In Denmark there is a renowned physician who is even a member of the government board of health, who uses vitamins to curb cancer. He has sent some of his patients to Dr. Arild Abrahamsen, and so have a number of doctors in Norway.

It is interesting to note that out of 10 medical doctors in Norway who get cancer themselves, 8 will not use the traditional methods with chemicals and radiation which they have used on their own patients because the system requires it, but they will turn to alternative treatments.

The Canadian Federal/Provincial government health program doesn't cover alternative or natural treatments.

DCA and Cancer Patients

The University of Alberta’s DCA Research Team is set to launch clinical trials on humans in the spring of 2007 pending government approval. Knowing that thousands of cancer patients die weekly while waiting for a cure, Dr. Michelakis and his team are working at accelerated speed, condensing research that usually takes years into months. Fundraisers at the University of Alberta are determined to raise the money to allow this next phase of research to begin. Once Health Canada grants formal approval, the University of Alberta’s Research Team will begin testing DCA on patients living with cancer. Results with regards to the safety and efficacy of treatment should be known late this year.

Letter from Dr. Evangelos Michelakis
March 15, 2007

Dear Friends:

Let me first express my heart felt thanks for all of your support. Our entire team has been overwhelmed with your messages of encouragement and hope. We have also heard many stories of heartbreak and loss which serve to accentuate the sense of urgency to find a viable and more humane treatment for cancer. Your support is helping us to move this important work forward.

The research plan for clinical trials, testing DCA as a cancer treatment in human beings, is complex and requires careful planning. We are aware that each day the research is delayed greatly impacts those of you who are living with cancer and those of you caring for someone with cancer. It’s been a mere six weeks since our initial results have been published and we now await approval of our research plan from Health Canada. The approval process will take a number of weeks and possibly months. We will continue to update the website when there are significant developments.

We are optimistic that we will be able to launch the trials within a matter of months, a process that normally takes several years. We are enjoying the support of the University of Alberta Faculty of Medicine & Dentistry and the Alberta Cancer Board, and help from people like you, makes us confident that we will at least succeed in completing this first trial. By itself, taking a drug from the laboratory all the way to completing a clinical trial, is a tremendously difficult process that is almost never completed without the direct support of pharmaceutical industry.

I want to thank all of you who have made contributions to the research fund. We’ve received generous donations, both small and large, from all over the world - from Canada, the USA, China, Holland, Australia, Greece, India, the Philippines and the UK. These funds, almost $100,000, have already helped us secure some of the supplies that we require. However, for the initial research in humans to start, we need to achieve our fundraising goal of $1.5 million. We need this groundswell of support from our global community to grow to insure our success.

On behalf of myself and the Steering Committee for the DCA study, I want to thank you for your caring support and generosity.

Yours truly,

Dr. Evangelos Michelakis

You are referring to Dr. Loraine Day?